Neurogenesis plays a critical role in the maintenance of the embryonic and adult brain, while alterations in this process lead to progression of neurodegenerative diseases 1 . Signaling through neurotrophic receptors is necessary for promoting neurogenesis, cellular development, survival and functional maintenance of neurons 2 . Neurotrophic factors such as nerve growth factor (NGF) binds to TrkA, and brain derived neurotrophic factor (BDNF) and neurotrophic factor 4 (NT4) bind to TrkB, while neurotrophic factor 3 (NT3) binds to TrkC 3 . Binding of neurotrophic factors with Trk receptors results in their dimerization and autophosphorylation, which triggers cell proliferation signaling cascades including PI3K/Akt, and Ras/Raf/MEK1/2/ ERK1/2 Map kinases 2 . These signals prevent neural cell injuries and induce cell proliferation, differentiation via activation of transcriptional factor CREB and up-regulation of anti-apoptotic BCl 2 protein 4 . In addition, NGF also interacts with p75 neurotrophin receptor (p75 NTR ) with lower affinity, which is a membrane protein belonging to the TNF receptor superfamily 5
Scientific RepoRts | 5:14038 | DOi: 10.1038/srep14038 derivatives of organic mercury compounds such as thimerosal and methyl mercury have been found to be linked with decreasing the process of TrkA autophosphorylation and neurite outgrowth in SHY-SY5Y and PC12 cells 11, 12 . Various reports have indicated that the organophosphate (OP) pesticide such as Chlorpyrifos has a critical role in inhibiting the survival of basal forebrain cholinergic neurons in rats via the inhibition of TrkA 13, 14 . In the last couple of decades, there have been extensive efforts to unravel the mechanistic understanding of impaired neurogenesis and associated disorders due to exposure to environmental chemicals. However, the basic mechanism(s) involved in environmental contaminant induced neurotoxicity are still poorly understood. Organophosphate (OP) pesticides are extremely poisonous to the developing as well as the adult brain 15 . Monocrotophos (MCP), a widely used organophosphate pesticide, is known to be neurotoxic. Thus, we attempted to investigate the role of TrkA activation and its downstream signaling pathways in MCP induced neurotoxicity in cultured rat brain neural stem cell (rBNSCs) derived neuronal cells and rat brain.
Neural stem cells (NSCs) are defined by their ability to self renew, proliferate and differentiate into neurons and glial cells, which are tightly regulated by extrinsic and intrinsic factors. New born neurons and glial cells then migrate to suitable regions in the brain, and incorporate into neural networks for the development of the nervous system. They are not only found in developing brain, but also in different areas of the adult brain and known to be involved in normal brain functioning, including the learning and memory processes, as well as recovery from brain injury 1, 16, 17 . NSCs in developing as well as adult brain are vulnerable to environmental neurotoxicants since they adversely affect the brain. Thus, we systematically investigated on primary cultures of rat brain neural stem cells (rBNSCs) and the findings were further correlated with in-vivo studies detailed in rat brain following experimental exposure to MCP.
Results
In-vitro studies. Characterization and neural differentiation of rBNSCs. Rat BNSCs isolated from embryonic day-12 (ED-12) rat fetuses showed over 95% viability (Fig. 1A) . The proliferative cells were able to develop the small neurospheres by day 7 in serum free neurobasal medium supplemented with growth factors (Fig. 1B) . The neurospheres attained maturity by day 20 (Fig. 1C) . Cells in neurospheres showed expression of both progenitor cell marker-nestin (green) and proliferating cell marker-BrdU (red) (Fig. 1D) . On the exposure to NGF (100 ng/ml) for 5 to 60 minutes, an induction in the phosphorylation of TrkA and downstream molecules (ERK1/2, Akt and CREB) was observed. This induction was maximum, when cells were exposed to NGF for 30 minutes (Fig. 1E ). Morphologically differentiated neural cells (over 95%) showed TrkA expression (Supplementary Figure-S1 ) and cholinergic specific marker ChAT (red color) (Fig. 1F ) and neural marker NF-M (green color) (Fig. 1G) .
MCP inhibits TrkA and its downstream signaling molecules and causes neuronal damage and apoptosis
in rBNSC derived neuronal cells. The cells exposed to MCP for 15 minutes inhibited the phosphorylation of TrkA, a signaling molecule known to trigger the cell growth and survival pathways by binding with NGF. The cells exposed to positive control-STS, an inhibitor of TrkA (non-specific), showed a higher magnitude of inhibition of phosphorylation of TrkA. No significant changes were observed in non-phospho TrkA expression when compared with unexposed control (Fig. 2A) . The MCP exposure for 15 minutes could not induce any significant change in the protein expression of JNK and p75 NTR (data not shown). The other downstream key signaling molecules (Akt, ERK1/2 and CREB), involved in TrkA pathway were also observed to be the significant inhibition in phosphorylation following MCP exposure (100 μ M). The lower concentration (10 μ M) of MCP was not as effective as to that of higher concentration of MCP (100 μ M) and positive control-STS. Such MCP exposure (24 h) induced alterations in the expression of TrkA and its downstream pathway molecules were found to be associated with inhibited expressions of neural markers (Tuj1, NF-M, GAP43, Neu-N) and the expression of cholinergic marker (ChAT) (Fig. 2B & C) . The increased expression of cytochrome-c, Bax, caspase-3/9 and reduced expression of BCl 2 also confirm the MCP induced apoptosis (Fig. 3A) . A significant DNA damage (TUNEL assay) in the cells also supports the apoptotic changes (Fig. 3B ). All such apoptotic changes were also found to be associated with the elevated levels of reactive oxygen species, malondialdehyde and decreased levels of intracellular glutathione and loss of MMP (Supplementary Figure-S2 ). A significant loss in cell viability could be associated with these apoptotic changes in the cells exposed to MCP (Fig. 3C) .
Pharmacological inhibitor studies. The role of TrkA and its downstream pathway molecules has been confirmed using molecule specific pharmacological inhibitors. Prior to receiving exposure to MCP (10 μM) for 24 h, cells were exposed to pharmacological inhibitors of TrkA (AG879: 5 μ M), MEK1/2 (U0126: 10 μ M), Akt (A6730: 5 μ M), JNK (SP600125: 10 μ M) and anti-oxidant (NAC: 10 μ M) for 1 h respectively. MCP induced effects became more pronounced in the cells pretreated with specific inhibitors of TrkA (AG879), MEK1/2 (U0126) and Akt (A6730), while specific inhibitors of JNK (SP600125), apoptosis (zDEVD) and anti-oxidant (NAC) have shown promoting effect on cell viability, when the data were compared with the MCP alone exposure (Fig. 4A) . Further, ICW analysis was done to study the association of MCP induced loss of cell viability with TrkA signaling mediated apoptosis. TrkA specific inhibitor (AG879: 5 μ M) showed significant alterations in the expression of pro-and anti-apoptotic marker proteins (Bcl 2 and Bax), when compared with the expression of these apoptotic proteins in both MCP exposed and unexposed cells. A reversible response to the MCP induced effects could be recorded in the cells receiving the exposure of specific inhibitors of JNK (SP600125: 10 μ M) and NAC (Fig. 4B ). In concurrence with these observations, the pre-treatment with a TrkA specific inhibitor (AG879: 5 μ M) was found to influence the MCP induced alterations in the protein expression of activated caspase-3, an executer caspase in mitochondria mediated apoptosis. A significant increase in the cleavage of PARP (116 kDa) into 89 kDa fragment was also recorded in the cells pre-exposed to the specific inhibitor of TrkA, when compared with cells exposed to MCP alone (Fig. 4C) .
Transfection studies. We explored the relationship between MCP-induced apoptotic signal transduction and TrkA receptor using RNA interference against TrkA receptor. Cells were transfected with specific TrkA si-RNA and then compared with the cells exposed to only MCP. The data were also compared with the basal (unexposed cells) and negative control (only siRNA). The data show a significant loss in viability in the cells transfected with TrkA-siRNA when compared with cells transfected with non-specific siRNA. The magnitude of viability loss was maximum in the cells exposed to only MCP (Fig. 5A) . MCP induced apoptosis via inhibition of TrkA was confirmed in transfected cells by the altered expression of proteins (immunocytochemical analysis) of Trk neurotrophin receptor -p75 NTR (with apoptosis marker cytochrome-c) and TrkA (with anti-apoptotic marker Bcl 2 ) (Fig. 5B) . The increased levels of p75 NTR and decreased expression TrkA protein were observed in cells transfected with TrkA-siRNA as well as in those exposed to only MCP, when compared with cells transfected with non-specific siRNA and non-transfected cells. Akt and ERK1/2 pathways are the most prominent downstream cell survival pathways of TrkA, so in the absence of TrkA receptor, p75 NTR receptors could mediate a different signaling pathway leading to apoptotic cell death via activation of c-Jun amino-terminal kinase (JNK). For exploring this possibility in our cell system, altered expressions of Akt, ERK1/2, pCREB, and pJNK1/2 proteins were compared between cells transfected with siRNA specific to TrkA receptor and cells exposed to MCP. Cells transfected with non-specific siRNA were used as negative controls while unexposed cells were used as basal controls. Cells transfected with TrkA receptor specific siRNA show a significant down-regulation in the protein expression of pERK1/2, pAkt, and pCREB, while there was an upregulation of activated caspase-3 and pJNK. More or less similar findings were recorded with cells exposed to only MCP. The cells transfected with non-specific siRNA were observed to be expressed near to the basal level (Fig. 5C ).
In-silico studies. Molecular docking studies-MCP inhibits TrkA receptor activation. Molecular docking studies were carried out to probe whether the MCP induced cell apoptosis was mediated through the inhibition of TrkA, and to gain an insight about the probable nature of MCP binding at the kinase domain of TrkA using crystal structure data. The binding site analysis of co-crystallized ligand AG-23(PDB ID: 4AOJ) revealed that the pyrazole group of the molecule interacts with the residues Glu-590 and Met-592 through H-bond interaction, whereas the isopropoxy group occupied the space between the residues Phe-589, Leu-567 and Ala-542 18 . The pyrimidine N3 atom binds to Asp-596 NH through a water molecule in the solvent-exposed region of the ATP binding site. The fluoropyridine ring of the AG-23 was placed in the hydrophobic cavity formed by the amino acid residues Leu-657, Asn-665, and Gly-667.
The co-crystallized inactive form of human TrkA protein (PDB ID: 4AOJ) with the inhibitor AG-23 was chosen for the molecular docking studies, and two non-specific inhibitors of tyrosine kinases (MCP and STS) as well as known TrkA inhibitor AG879 were subjected to rigorous docking and scoring protocol. To evaluate the correct binding prediction of the docking program, the co-crystallized ligand AG-23 was initially docked at the active site of the human TrkA protein. The comparative analysis of binding site between docked poses and X-ray crystal structure of AG-23 revealed that there is no significant change in the binding mode of AG-23, both in terms of ligand conformation and the binding amino acid residues, thus suggesting the correct binding prediction of docking program (Fig. 6B) . Figure 6A summarizes the GOLD docking score along with the free energies (Δ G) for each protein-ligand complex. Among the four TrkA inhibitor molecules, AG-23 showed highest docking score, while the docking score of MCP was less than AG-879. We extended the studies to calculate the free energy (Δ G) for each protein-ligand complex, which gave more insights about the inhibitor binding. The binding free energy (Δ G bind ) data correctly corroborated with the experimental TrkA inhibitory activity, where the binding free energy (Δ G bind ) for STS was maximum (181.39 kcal/mol) among the four TrkA inhibitors, followed by AG-23, AG-879 and MCP. The least docking score as well as the value of Δ G bind of MCP indicated that although MCP inhibits the TrkA activity, its inhibitory potency is weak among the four TrkA inhibitors given in Fig. 6A .
The binding pose analysis of MCP at the kinase domain TrkA revealed that it's double bonded oxygen of the phosphate group showed the H-bond interaction with Arg599 residue, while the methyl group was attached with O-4 atom and placed towards the cavity surrounded by the residues Arg593, Tyr591, and Gly595. The methylamino group occupied the cavity surrounded by the residues Leu516, Val524, Leu657 and Gly517, while the methyl group attached to C-2 carbon was directed towards Met592 and Arg593 (Fig. 6C ). Protein changes expressed in relative fold change by comparing the data with respective unexposed control at 800 nM. Sapphire700 stain and DRAQ5 stain was used as normalisation dye at 700 nM. Proteins expressions were analyzed with Odyssey CLX Li-cor software. The data represent means ± SE of four independent experiments. *p < 0.05; **p < 0.01 (unexposed control vs experimental group). The docking pose analysis of STS at the kinase domain TrkA revealed that its methoxy, amino and methyl groups at one end were occupied by solvent-exposed region surrounded by the residues Leu-516, Gly-517, Val-524, Gly-595 and Asp-596, whereas, at the other end the ketonic group was joined by indole nucleus exposed to solvent-accessible residues namely Leu-657, Asp-668, Ala-542 and Val-573. The ketonic oxygen of STS showed the covalent interaction with Gly-667 resulting in its highest inhibitory potency. The docking pose analysis of AG-879 at the kinase domain TrkA revealed that the amino end of the molecule was involved in H-bond interaction with crucial Met592, while the hydroxyl moiety attached to the phenyl group showed water mediated H-bond interaction with the residues Asp-668, Gly-667 and Lys-544. The tert-butyl group attached with C9 atom of the molecule was exposed to the cavity formed by the residues Gly-667, Lys-544, Leu-657 and Val-573, while the tert-butyl group attached with C7 atom of the molecule was surrounded by the residues Ala-542, Arg-654 and Gly-595.
In Vivo studies. MCP induces apoptosis in rat brain by altering the TrkA and p75
NTR mediated signaling. The protein expression studies were carried out for TrkA/p75 NTR system, Akt/ ERK signaling pathway molecules and JNK pathways for apoptosis signaling in the brain of adult rats exposed to MCP (10 mg/kg body weight, p.o., single dose). Both immuno-histochemistry and western blot data showed a significant inhibition in the TrkA activation and up-regulation of p75 NTR in the hippocampus of the brain of animals exposed to MCP. Although, MCP induced downregulation in the expression of TrkA and increased the levels of p75 NTR were observed in both hippocampus and frontal cortex, the effect was more prominent in hippocampus region (Fig. 7A) . In concurrence with the in-vitro findings, we observe that MCP exposure significantly down-regulates the expression of pERK1/2, pAkt, and pCREB, while up-regulates the expression of pJNK in both frontal cortex and hippocampus regions of the brain (Fig. 7B i) . The magnitude of altered expression of these proteins was higher in hippocampus than in frontal cortex region. The subsequent effect in the expression of marker proteins of apoptosis caspases 3 and neuronal markers (Tuj1, ChAT) was also recorded in both hippocampus and frontal cortex regions of exposed brain (Fig. 7B ii & iii) . MCP induced activation of these apoptotic cascades have also led to significant DNA fragmentation which was confirmed by TUNEL assay (Supplementary Figure-S3 ).
Neurobehavioral studies. MCP exposed rats showed a significant impairment in spontaneous locomotor activity as reflected by the decrease in total distance travelled (41%, p < 0.01), moving time (36%, p < 0.05), stereotypic count (47%, p < 0.05) and increase in resting time (22%, p < 0.01) as compared to the control group (Fig. 8A) . A significant (21%, p < 0.05) loss of forelimb grip strength was also recorded in MCP exposed rats (Fig. 8B) . MCP exposure also induced significant (p < 0.001) deficits in learning and memory in the experimental rats as confirmed by 'Y' maze analysis (Fig. 8C & D) . The neurobehavioral studies confirmed significant functional impairment in spontaneous motor activity, grip strength and learning memory in rats experimentally exposed to MCP.
Discussion
The multiple effects of TrkA including NGF-induced neuronal differentiation and hindrance of programmed cell death has been widely studied 8, 19, 20 . NGF is known to play a key role in the development of neuronal cells of central as well as peripheral nervous systems 21 . NGF and other neurotrophins bind to specific receptors, tyrosine kinases (Trks)/p75 NTR at the cell surface and activate them for differentiation/ apoptosis. Such events also initiate the internalization of the activated receptors into vesicles, hence remain active for a longer period 22 . The binding of NGF to its specific receptors viz., TrkA and p75 NTR leads to a series of downstream signaling events which ultimately mediates neuronal survival, differentiation, and maintenance. PI3K/Akt/β -Catenin and MAPKs are major pathways involved in neuronal survival and differentiation 4, 23 . Though, we have earlier reported MCP-induced impairment in survival and differentiation in rat pheochromocytoma cells by altering these pathways 24, 25 but the role of TrkA/ p75 NTR signalling on these alterations have not been determined so far. Thus, we investigated the effects of MCP on regulating TrkA/p75 NTR trafficking, associated downstream signaling events and subsequent injuries in neuronal cells derived from rat brain neural stem cells (rBNSCs).
It has been demonstrated that TrkA signaling plays a key role in the induction of proliferation and differentiation of neural stem cells (NSCs) during brain development 3, 26 , and altered levels of TrkA receptor have been found to be associated with neurodegeneration and disease progression in Alzheimer's and Parkinson's disease 27, 28 . Biological interactions between environmental toxicants and brain NSCs may lead to irreparable damages in the brain 29, 30 . Hence, NSCs could be an adequate system of choice for studying chemical induced neural injury and repair. In the present investigation, we show that the neuronal cells derived from rat brain neural stem cell (rBNSC) have the significant activity of TrkA and its downstream molecules ERK1/2, Akt and CREB and a range of phosphorylation by NGF after the withdrawal of mitogenic factors i.e., EGF and bFGF. These neuronal cells were having the significant expression of neuronal markers including cholinergic ChAT and neuronal morphology.
We investigated if the MCP induced apoptosis and subsequent neurotoxicity in neuronal cells derived from rBNSC was triggered through TrkA signaling. Our results demonstrate a significant inhibition in the phosphorylation of TrkA and subsequent inhibition in the TrkA mediated downstream key signaling molecules that lead to inhibition of pro-survival ERK1/2 and Akt signaling in stem cell derived neuronal cells, exposed to MCP. Such MCP induced inhibition in the expression of TrkA and other signaling molecules was found to be associated with the altered expressions of neural markers (Tuj1, NF-M, GAP43, Neu-N) including cholinergic (ChAT) expression. The increased expression of cytochrome-c, Bax, caspase-3/9 and reduced expression of BCl 2 in our studies have also confirmed the mitochondria mediated caspase cascade induced apoptosis due to MCP exposure. Further, a significant DNA damage, oxidative stress and subsequent loss of cell viability also supports the MCP induced apoptotic changes.
The MCP induced inhibition in the pathways of survival signals and activation of death signals was further confirmed using pharmacological inhibitors. We observed that cells pre-treated with JNK1/2 inhibitor (SP600125) protect themselves from MCP-induced apoptosis, which suggests the critical involvement of the JNK pathway in MCP mediated toxicity in neural cells derived from rBNSCs. Similarly, pre-treatment of inhibitors of TrkA, ERK1/2 and Akt significantly increased the MCP induced cell death in comparison to the experimental group exposed to MCP alone. These findings also suggest the critical role of activation of TrkA, ERK1/2 and Akt in anti-apoptotic activity against MCP exposure. Our data also correlate the TrkA mediated ERK1/2 and Akt inhibition with MCP induced apoptosis and neuronal injuries. The data show that MCP-induced cell death involves not only inhibition of survival signals, but also simultaneous activation of a death signal by p75 NTR . NTR , p-Akt, Akt, p-ERK1/2, ERK1/2, p-CREB and p-JNK, (ii). apoptosis cells marker caspases-3 and (iii). neural markers such as Tuj1 & ChAT and were studied in the frontal cortex and hippocampus regions of rat brain following the exposures to MCP (10 mg/ kg body weight, p.o., for 7 days). β -actin was used as an internal control to normalize the data. and co-receptors 32 . The p75 NTR exerted mechanisms of inhibition of TrkA have been suggested as one among the important factors accelerating neurodegenerative disorders 33, 34 . Thus, to find out the cross talk between TrkA receptor inactivation and p75 NTR receptor activation, we made a TrkA receptor gene expression silencing using specific siRNA in rBNSCs. The substantial reduction in the expression of TrkA was recorded in TrkA specific siRNA transfected cells, which was comparable to the reduced expressions of TrkA due to MCP exposure in the other set of cells. The cells transfected with non-specific siRNA did not show any reduction in the expression of TrkA. These reduced expressions of TrkA were inversely proportional to the increased expression of p75 NTR in TrkA specific siRNA transfected and MCP exposed cells. The findings demonstrated the triggering of MCP induced neurotoxicity by inhibition of TrkA signaling and activation of p75 NTR cascades. The decrease in the TrkA expression and a parallel increase in the level of p75 NTR has also been reported during normal aging as well as in AD 35, 36 and suggests that such individuals may be more susceptible to organophosphate pesticide related neurotoxicity.
The involvement of TrkA/p75 NTR dependent signaling cascades including ERK1/2, Akt and JNK1/2 signaling pathway in MCP induced neurotoxicity was reconfirmed by significant downregulated expression of pERK1/2, pAkt, pCREB along with upregulation of activated pJNK. These events could have been correlated well with altered markers of apoptosis signaling and decreased expression of cell survival pathways, thus suggesting neurodegeneration. Since, a fine balance between ERK1/2, Akt and JNK1/2 signaling pathways has been demonstrated as an important event in the maintenance of proper neural cell proliferation and differentiation during brain development 37, 38 . ERK1/2 upon activation by TrkA leads to increase in the expression of transcription factor CREB 39 that plays an important role in maintaining neural plasticity, survival and long-term memory 40 , while Akt phosphorylated by TrkA is considered to be one of the keys of pro-survival pathways within the cell and regulate apoptosis 41 . The impairment of Akt signaling activates the mitochondria mediated apoptosis process as confirmed by the increased expressions of cytochrome-c, the executor caspase to induce the apoptotic cell death 42, 43 . Though, the finding of the present investigations relveal the MCP induced neurotoxic reposnses are primarily mediated through TrkA/p75 NTR dependent signaling cascades, but our previous findings for MCP also confirm the significant involvement of Akt. These in silico studies indicated that MCP has the binding affinity for kinase protein Akt and play a critical role in MCP induced neurotoxicity in stem cell derived neuronal cells of human 44 . Therefore, the docking studies together suggest that the MCP may occupy the common binding site present in both of these proteins resulting into the inhibition of these proteins. Based on the findings of our previous and present investigations, it is also being inferred that MCP has a non-selective inhibitor of Akt and TrkA.
In concurrence to the in-vitro and in-silico findings, the significant neurotoxic responses and activation events associated with apoptotic signaling cascade and DNA damage were observed in hippocampus and frontal cortex regions of the brain of rats exposed to MCP. These neurotoxic responses could be well correlated with standard endpoints of neurobehavioral deficits viz., locomotor activity, grip strength and Y maze, which finally reflect cholinergic impairment 45, 46 . Similar to in vitro findings, there was a significant inhibition in the expression of TrkA and associated downstream pathway molecules, while upregulation of p75 NTR signaling molecules was observed in the hippocampus and frontal cortex regions of rats exposed to MCP. These findings together suggest that MCP induces neurotoxicity by altering the molecular mechanism of switching of TrkA/p75 NTR signaling. The exposure to MCP could be a potential threat for further neurodegeneration in patients of AD, PD and other neurodegenerative diseases. The schematic diagram showing the possible mechanism of action of MCP induced neural cell death could be drawn by observing the results of the current study (Fig. 9) .
Conclusion
We have demonstrated the molecular switching mechanism of TrkA/p75 NTR signaling in MCP induced neurotoxicity under both in-vitro (cultured rat brain derived neural cells) and in-vivo (rat brain) conditions. Since, both the receptors, i.e., TrkA and p75 NTR bind to NGF and known to interact, it may be possible to fine tune for their proper action in the form of proliferation, differentiation and injuries 47 . The data also identify the neurotoxicity mechanisms of organophosphate pesticide-MCP, and provides useful information to evince that pesticide-induced neurotoxicity may be an important risk factor for neurodegenerative diseases. The exposure to this pesticide may further increase the intensity of neurodegeneration in the patients suffering from AD, PD and other neurodegenerative disorders. 
Material and Methods
Reagents and consumables. All the specified chemicals, reagents, diagnostic kits were purchased from Sigma Chemical Company Pvt. Ltd. St. Louis, MO, USA, unless otherwise stated. Culture medium, antibiotics, serum and growth factors were purchased from Gibco BRL, USA.
In Vitro studies. Isolation and characterization of neural stem cells (NSCs).
NSCs were isolated from the embryonic day-12 (ED-12) rat fetuses (elaborated in supplementary material). Small proliferating neurospheres appeared after 1 week, which matured by day 20. The neurosphere culture was passaged at an interval of 10-12 days by gently triturating the neurospheres and re-plating the single cell suspension of NSCs. The NSCs were characterized by using anti-nestin and anti-BrdU antibody (elaborated in supplementary material.
Neuronal differentiation of NSCs. After passage # 5, dissociated neurospheres were plated on poly-L Lysine (PLL) coated flasks (5 × 10 4 cells/Cm 2 ) in serum free neurobasal medium containing DMEM: F12 (1:1) supplemented with N-2 (1%), B-27 (2%) and mitogenic factors (10 ng/ml bFGF & EGF). For inducing cholinergic differentiation, cells were incubated in differentiation medium containing NGF (100 ng/ml) with reduced concentrations of EGF and bFGF (1 ng/mL), B-27 (0.1%) and N-2 (1%). Immediate after placing the cells in the differentiation medium, the analysis was done to study the initiation in the expression of signaling cascade molecules involved in neural differentiation i.e., TrkA and its downstream molecules (ERK1/2, Akt and CREB). The expression of signaling molecules was assessed for 5 to 60 min. Differentiation medium was changed every alternate day. Neuronal differentiation was confirmed by assessing the morphological appearance and expression of cholinergic (ChAT) and neurofilament medium (NF-M) proteins. For the experimental purpose, confluent growing cells were sub-cultured in PLL pre-coated six-well culture plate and 75-Cm 2 culture flask.
Identification of non-cytotoxic doses of monocrotophos (MCP).
Prior employing in the expression studies, non-cytotoxic doses of MCP were ascertained using standard endpoint i.e., tetrazolium bromide MTT assay as described by Agrawal et al. Cell signaling pathway, neural markers and apoptosis marker studies. The altered expression of marker proteins of signaling cascades (P-TrkA, TrkA, p75 NTR , p-Akt, Akt, p-ERK1/2, ERK1/2 and p-CREB, p-JNK), neural markers (TUJ1, NF-M, Neu-N, GAP43, ChAT) and apoptosis markers (Bax, BCl 2 , Cytochrome-c, Caspases 9/3 and PARP) were studied in stem cell derived neuronal cells. Proteins harvested from experimental and control groups were processed for Western blot analysis following our protocol 49 . The immunocyotochemical localization of the signaling marker proteins was also done following the protocol described earlier 50, 51 .
Signaling molecule inhibition studies. The role of TrkA and its downstream pathway molecules has been confirmed using molecule specific pharmacological inhibitors. The cells were seeded in PLL pre-coated 96 well culture plates and allowed to adhere for 24 h prior to the experimental exposure. The cells were exposed in two different groups i.e., MCP (10 μ M) for 24 h (Group-1) and in Group-2, cells were exposed to either of pharmacological inhibitors of TrkA (AG879: 5 μ M), MEK1/2 (U0126: 10 μ M), Akt (A6730: 5 μ M), JNK (SP600125: 10 μ M), apoptosis (zDEVD: 10 μ M) and anti-oxidant (NAC-10 μ M) for 1 h prior the exposure to MCP (10 μ M) for 24 h. The cells of both the groups were processed for MTT assay.
In-cell western (ICW) assay. ICW was carried out for specific marker proteins i.e., Bax and BCl 2 using ICW kit of LI-COR Biosciences as described by the manufacturer. Briefly, 10,000 cells were seeded in each well of 96 well plates and exposed to MCP (10 μ M) or to the following inhibitors of TrkA (AG879: 5 μ M), JNK (SP600125: 10 μ M) and anti-oxidant (NAC-10 μ M) for 1 h followed by MCP (10 μ M) exposure for 24 h. Cells were washed with PBS and fixed with 3.7% paraformaldehyde for 20 minutes. After fixation, cells were washed three times with 1X PBS containing 0.1% triton X-100 for permealization. Blocking was done by incubating in Odyssey blocking buffer for 1.5 h at room temperature. Primary antibody against Bcl2 (1:100) and Bax (1:100) was diluted in blocking buffer and added to the cells and the plates were gently shaked for 3 h. After 3 hours of incubation, plates were washed with PBS containing 0.1% tween-20 thrice. Similarly, secondary antibody raised against rabbit and labeled with IR Dye 800 CW was diluted in Odyssey blocking buffer at 1:800 dilution. The secondary antibody solution also contained a mixture of Sapphire700 stain (1:1000) and DRAQ5 stain (1:10,000), which acts as a normalisation dye. The above mixture was then added to the cells and gently shaken for 1 h at room temperature in dark. Finally, the cells were washed with PBS containing 0.1% tween-20 thrice by gentle shaking. Before scanning on LI-COR, Odyssey CLx machine, plates were dried by inverting them on tissue paper. After imaging at 700 and 800 nm channels, analysis was done using Image Studio 2.1.1.0
Western blot analysis. The involvement of TrkA and its downstream signaling molecules was also studied by western blot analysis. The experimental groups and exposure period were identical as were used in in-cell western assay.
Transfection study. The involvement of the TrkA mediated signaling cascade was further confirmed by blocking the expression of the TrkA receptor using specific siRNA (Silencer R selected pre-designed SiRNA, Ambion, 4390771) and compared it with the altered expression of TrkA and mediated signals with MCP exposed cells. For studying the specific activity of TrkA receptor siRNA, a set of cells transfected with negative control siRNA (on target plus control pool non-targeting pool, Thermo Scientific, D-001810-10-05) was also run under identical conditions. Unexposed cells were used as basal control. About 80% transfection efficiency was achieved and confirmed (supplementary figure-S 5) by CY3 siRNA (silencer CY3 labeled negative control siRNA, Ambion, AM4621)) using Lipofectamine 2000 (Invitrogen). Cells were used in the study post day 2 of transfection. The analysis was done using percent cell viability (MTT assay) and altered protein expression (western blotting and immunocytochemistry).
In Silico studies. Molecular docking protocol. The docking experiments were carried out using the GOLD docking program (GOLD, Version 3.1; Cambridge Crystallographic Data Centre: Cambridge, UK). The atomic coordinates of TrkA (PDB ID: 4AOJ) were downloaded from the Brookhaven Protein Data Bank (www.rcsb.org) and prepared using a protein preparation wizard where bond orders were assigned, water and other residues except bound ligands were deleted, and finally the protein was backbone constrained minimized using OPLS-2005 force field implemented in Schrödinger software package (Schrödinger, version 9.1; Schrodinger, LLC: New York, 2005) . The bond conformation of co-crystallized AG-23 was used as control for defining the active site in TrkA. The optimized 3D-structures of new ligands were docked within 10 Å radius by running 20 genetic algorithm (GA) steps for each. The docked poses of geometry optimized ligands were ranked using the Gold Score (GS), and were used to find the most optimal binding pose of each ligand. In the GOLD program, the default parameters such as population size (100); selection-pressure (1.1); number of operations (10,000); number of islands (1); niche size (2); and operator weights for migrate (0), mutate (100) and crossover (100) were applied. The top five binding poses of each ligand were analyzed, to select the best binding pose of each ligand, in order to untangle the essential parameters in terms of direct-(H-bonds) and indirect (hydrophobic) interactions governing binding disparities among the series of these compounds. The binding free energies (Δ G bind) for each protein-ligand complex were calculated using Generalized Born Surface Area (MM/ GBSA) methods implemented in Schrödinger software package (Schrödinger, version 9.1; Schrodinger, LLC: New York, 2005).
In Vivo studies. Animals and treatment schedule. The protocol for the study was approved by the Institutional Animal Ethics Committee of CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, India, and all experiments have been carried out in accordance with the guidelines laid down by the committee for the purpose of control and supervision of experiments on animals, Ministry of Environment and Forests (Government of India), New Delhi, India. Wistar rats weighing 180 ± 20 gm obtained from the animal breeding colony of CSIR-IITR, Lucknow, India, were housed in polypropylene cages under standard hygiene conditions with a 12 hour light/dark cycle at 25 ± 2 °C and fed a pellet diet (Ashirwad Industries, Chandigarh, India) and water ad libitum. Following randomization and acclimatization, animals were divided into experimental and control groups. The single dose of MCP (10 mg/kg body weight) was administered by oral gavage to the experimental animals, while the vehicle control group was given corn oil under identical experimental conditions. MCP induced alterations in the functional phenotypic expression were evaluated by key neuro-behavioral endpoints such as, locomotor activity, grip strength and 'Y' maze a day prior to sacrificing the animals i.e., 7 th day after the dosing 52 . The other set of animals was used to study regional specific marker proteins in two different parts of the brain. Following perfusion, brain was collected immediately, washed in ice cold normal saline (0.9% NaCl) and dissected into brain regions following the standard procedure of Ansari et al. 53 and processed for immunohistochemistry and western blot analysis.
Immunohistochemistry. Immunohistochemical studies were carried out following the method of Ansari et al. 53 . The intensity of anti-TrkA and anti-p75 NTR in the hippocampal region of the brain was determined using a computerized image analysis system (Leica Qwin 500 image analysis software) as described by Shingo et al. 54 .
Western blot analysis. After exposure to MCP, expression changes in the frontal cortex and hippocampus region of rat brain was assayed following the method of Yadav et al. 55 . The marker proteins analyzed to study the altered expression were same as studied in the in vitro studies. The brain regions were homogenized and proteins were isolated for further processing as per the protocol of Yadav et al. 55 .
Behavioral studies.
(a) Spontaneous motor activity: Spontaneous motor activity in rats was assessed using computerized Actimot (TSE, Germany) following the method as described by Yadav et al. 56 . Effect on different parameters including total distance travelled, resting time, time moving and stereotypic count was studied in the exposed groups. (b) Grip strength: A computerized grip strength meter (TSE, Germany) was used to measure the forelimb grip strength in the control and exposed rats following the standard procedure as described by Yadav et al. 56 . (c) Y maze: Spatial memory task was tested by using Y maze (TSE, Germany) following the procedure of Wang et al. 57 . Entry to the arms was scored as soon as the front paws of the rats crossed into an arm. The results are expressed in percentage of time spent and percentage of entries in comparison to novel arms versus other arms.
Statistical analysis.
Results are expressed as mean ± standard error of mean (SEM) for the values obtained from at least three independent experiments. Statistical analysis was performed using one-way analysis of variance (ANOVA) using Graph Pad Prism (Version 5.0) software. The values *p < 0.05 were considered as significant, **p < 0.01 more significant and ***p < 0.001 highly significant.
